A Comparative Study of Effects of Berry and Grain Products on Postprandial Glycemic Response in Healthy Subjects
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01575509 |
Recruitment Status :
Completed
First Posted : April 11, 2012
Last Update Posted : June 15, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Healthy | Other: Berry product Other: Bread product Other: Glucose control solution Other: Glucose-fructose control solution | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 14 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Official Title: | A Clinical, Randomized, Comparative Study of Effects of Berry and Grain Products on Postprandial Glycemic Response in Healthy Subjects |
Study Start Date : | March 2012 |
Actual Primary Completion Date : | June 2012 |
Actual Study Completion Date : | June 2012 |
- Other: Berry product
Sugar infused dried lingonberry
- Other: Bread product
Brown bread
- Other: Bread product
Whole grain bread
- Other: Glucose control solution
Glucose solution with a corresponding amount of carbohydrates as provided by the bread test products
- Other: Glucose-fructose control solution
Control solution with a similar carbohydrate content as provided by the dried lingonberry test product
- The 2 hours glycemic responses to test products and control solutions [ Time Frame: 2 hours ]Capillary blood samples are taken before and at 15, 30, 45, 60, 90 and 120 min after starting to eat the test products or control solutions for measurements of plasma glucose concentrations.
- The 2 hours insulinemic responses to dried lingonberry product and corresponding control solution [ Time Frame: 2 hours ]Capillary blood samples are collected before and at 15, 30, 45, 60, 90 and 120 min after eating the lingonberry test product and glucose-fructose control solution. The serum insulin concentrations are analysed.
- The incremental area under glucose curve (IAUC) of bread test products [ Time Frame: 2 hours ]IAUC (mmol/l x min) is determined using the trapezoidal method for each subject and bread test product and corresponding glucose control solution.
- Glycemic index (GI) of bread test productsThe GI is calculated as a percentage of the glucose IAUC values of a bread product and a glucose control solution.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- voluntary given written concent for participation in research
- healthy man or woman, age between 18 and 65 years
- regular eating
- Body Mass Index 18,5 - 29,9 kg/m2
Exclusion Criteria:
- diabetes
- gastrointestinal diseases
- hepatic, kidney, pancreas or thyroid disease or disorder
- arthritis
- pregnancy or breast feeding
- smoking
- allergy
- severe diseases
- blood donation

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01575509
Finland | |
Clinical Life Sciences Ltd | |
Kajaani, Finland, 87100 |
Principal Investigator: | Päivi Cheney, MD |
Responsible Party: | Clinical Life Sciences Ltd. |
ClinicalTrials.gov Identifier: | NCT01575509 |
Other Study ID Numbers: |
MAVI |
First Posted: | April 11, 2012 Key Record Dates |
Last Update Posted: | June 15, 2012 |
Last Verified: | April 2012 |
Pharmaceutical Solutions |